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ABSTRACT
Patients envenomed by Lonomia sp caterpillars initially experience a mild burning pain, 
headache, nausea, vomiting, and skin and mucosal hemorrhages. Some patients can rapidly 
progress to a severe coagulopathy that presents as visceral or intracerebral hemorrhaging. 
We studied the hemostatic alterations that occurred in 14 patients who were envenomed 
by Lonomia obliqua in Southern Brazil and presented at the Hospital São Vicente de Paulo 
(Passo Fundo, RS), Brazil during the summers of 1993 and 1994 when Lonomia antivenom 
was not yet available for treatment. The patients were classified into to 4 clinical groups: 0 
(two patients), I (eight patients), II (two patients), and III (two patients). The patients were 
admitted to the hospital between 4 hours and five days after contact with the caterpillars. In 
this study, the coagulation parameters of the patients were followed up for up to 172 hours 
after the accidents. The patients received no treatment with the exceptions of two patients 
who received blood transfusions and antifibrinolytic treatment. The observed abnormalities 
related to blood coagulation and fibrinolytic factors were similar regardless of the severity 
of the bleeding symptoms. These findings suggest that alterations in hemostatic parameters 
without thrombocytopenia are not predictors of the seriousness of such accidents. Thus, 
consumptive disorder and reactive fibrinolysis are not proportional to mild coagulopathy. 
Furthermore, these patients recovered. The hemostatic parameters of most of the patients 
normalized between 96 and 120 h after the accident. 
KEYWORDS: Lonomia obliqua caterpillar. Hemorrhagic syndrome. Coagulopathy. 
Fibrinolysis.
INTRODUCTION 
A bleeding syndrome induced by skin contact with Lepidoptera (Saturniidae) 
caterpillars was described for the first time in Brazil by Alvarenga in 19121. At this 
time the responsible caterpillar genus was not known. A similar bleeding syndrome 
caused by the Lonomia achelous moth caterpillar (Saturniidae) was first described 
in Venezuela in 19672,3 and was later reported in the North of Brazil4. Accidents 
with Lonomia obliqua5 caterpillars were observed for the first time in the South of 
Brazil in 1989 around the municipal districts of Passo Fundo (RS) and Chapecó 
(SC). By 1992, accidents with the caterpillars assumed epidemic proportions as 
incidence of such accidents grew annually. The main clinical characteristic of 
Lonomia (L) obliqua accidents is a hemorrhagic syndrome associated with acute 
renal failure6,7. In general, the symptoms include local pain and burning, headache, 
nausea and vomiting, extensive ecchymosis in the contact areas, hematomas, gingival 
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bleeding, epistaxis, hematemesis, melena, hematuria 
and metrorrhagia8,9. Acute renal failure and intracerebral 
bleeding are among the most severe complications of 
L. obliqua accidents and are also among the principal 
causes of death7,10,11. 
Two procoagulant toxins have been identified in 
L. obliqua bristle extract, i.e., a factor X activator12 and a 
prothrombin activator serine protease13, and these toxins 
are most likely responsible for the intravascular thrombin 
formation that directly consumes the coagulation factors14. 
The lethality of lonomic envenomation in the absence of 
specific treatment is 1.5 to 2.0%, which is approximately 3 
to 4 times greater than the lethality of snakebites15. Before 
serum therapy, previous experiences in Venezuela showed 
that replacement therapies with whole blood, fresh or 
frozen plasma, or cryoprecipitates contribute to the adverse 
clinical consequences of envenomation most likely because 
this type of treatment provides additional clotting factors 
that exacerbate the intravascular coagulation induced by 
the circulating toxins. The cessation of clinical evidence 
of bleeding has been reported following treatment with 
purified human fibrinogen and antifibrinolytic drugs, such 
as aprotinin and ε-amino caproic acid (EACA)3,16.
In Venezuela, skin contact with Lonomia caterpillars 
is mainly treated using Trasylol (aprotinin), and in Brazil, 
this condition is successfully managed using antilonomic 
serum therapy, which is effective in normalizing coagulation 
disturbances and hemorrhagic syndrome17,18,19. Moreover, 
the number of fatal cases is reduced with the use of serum 
therapy15. Studies of patients envenomed by L. obliqua 
caterpillars have shown that at the time of arrival at the 
hospital, a consumption coagulopathy associated with 
intravascular thrombin generation triggering secondary 
fibrinolysis9. In contrast, patients envenomed by Lonomia 
achelus caterpillars exhibit a primary fibrinolytic action16 
due to their fibrinolytic enzymes. Despite these results, the 
complex pathological mechanism by which the hemorrhagic 
syndrome is caused by L. obliqua envenomation remains 
incompletely elucidated. The presence of high amounts of 
dimer-D in some patients in combination with nearly normal 
level of fibrinogen is still not well explained and neither are 
the rare thrombocytopenia events in patients with moderate 
and severe coagulopathies. The majority of reports present 
only the coagulation factor levels at admission. Here, we 
present a long-term follow-up clinical and laboratory 
data study concerning hemostatic disturbances in patients 
who had been envenomed by L. obliqua in Brazil. Our 
results show that the majority of patients who present with 
incoagulable blood without bleeding can normalize within 
96-120 h after contact with the caterpillars. In contrast, 
patients who are treated with Lonomia antivenom recover 
within 20 h of treatment19 and thus avoid the considerable 
risks of bleeding and some systemic complications.
MATERIAL AND METHODS
Patients
The study was performed with 14 patients (Ps) who were 
admitted to the Hospital São Vicente de Paulo (HSVP), Passo 
Fundo, Rio Grande do Sul, Brazil, during the summers of 1993 
and 1994 when Lonomia antivenom was not yet available for 
treatment. Patients with a history of contact with caterpillars 
and with some clinical evidence of envenomation (local pain, 
edema, bleeding, hematomas, etc.) and patients who brought 
the caterpillars to the clinic were considered in this study. 
These caterpillars were sent to the Instituto Butantan (IBu), 
São Paulo, Brazil for species identification. The patients 
were classified into the following four clinical groups based 
on the treatment experience at the hospital: Grade 0 patients 
were asymptomatic with no blood coagulation changes 
or bleeding of any type during 72 h of follow-up; Grade I 
patients exhibited bleeding symptoms with blood coagulation 
changes (i.e., incoagulable blood or prolonged clotting 
times); Grade II patients experienced ecchymosis, epistaxis, 
gingival bleeding, hematomas, bleeding from scars or recent 
wounds with no hemodynamic changes, and altered blood 
coagulation parameters; and Grade III patients exhibited 
macroscopic hematuria and hemorrhages in the digestive 
tract, lungs, peritoneum and central nervous system. The 
bleeding was occasionally accompanied by hemodynamic 
disturbances, acute renal failure, respiratory failure, adynamic 
ileum, changes in cognition, and/or altered blood coagulation 
parameters (Table 1). 
This study was approved by the Ethics Committee of the 
HSVP (RS), Brazil. Written informed consent to participate 
was obtained from the patients or their relatives.
Blood samples
The first venous blood sample was either obtained 
shortly after admission (P01, P03, P04, P05, P11, P12, and 
P14), after the patient was under observation at the hospital 
for 5, 13, or 16 h (P06, P07, and P08), or 1 (P02 and P13), 
3 or 4 days (P09 and P10,) before being included in the 
study. The delay times between blood collection and the 
assays are indicated in Table 2.
Blood was collected in 10% EDTA-Na2 with 10 µL 
of antilonomic serum produced by the IBu (SP) for the 
laboratory analyses. For the biochemical analysis, serum 
samples were routinely collected and assayed in the 
HSVP laboratory. The coagulation assays were performed 
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Table 1 - Background information on 14 patients on admission to HSVP
Patient  Site of contact, age, sex Interval* 
(hours)
Grade Developed symptoms 
01 R. hand (fingers), 25, M. 7 0 -
02 -   3, M 24 0 -
03 Back, 12, M 6 I L. pain, erythema, cephalea, GID, dizziness
04 R. hand, 7, M 7 I L. pain, edema
05 R. hand, 36, M 7 I L. pain, cephalea, dizziness
06 Le. forearm, 13, F 7 I L. pain, edema, cephalea
07 Le. hand (finger), 8, M 8 I L. pain, erythema, cephalea, GID
08 R. hand (finger), 71, F 24 I L. pain, erythema, cephalea, GID 
09 Le fingers, 63, F 4 I L. and general pain, edema, cephalea, GID, dizziness 
10 R. hand, 8, F 24 I L. pain, erythema, edema, arthralgia
11 R. hand, 3, M 48 II L. pain, ecchymosis, bleeding, hematomas
12 R. thigh, 12, M 120 II L. pain, ecchymosis, dizziness, gingivorrhagia, hematomas
13 R. hand (fingers), 11, M < 24 III L. pain, erythema, macroscopic hematuria, hematoma (R. arm), 
arthropathy (R. elbow)
14 R. hand, 14, F 48 III L. pain, edema, post-trauma: pulmonary and peritoneal hemorrhagia., 
vomiting, hypotension
GID- gastrointestinal disturbance,  M-male,  F–female, R-right, Le-left, L-local. *- Time elapsed between accident and blood col-
lection; HSVP- Hospital São Vicente de Paulo
Table 2 - Blood coagulation and fibrinolytic parameters in 12 patients after the accidents with Lonomia oblique caterpillar, on admission
Assays Patients X±SEM Min-max values (Normal X±SEM )
Fibrinogen (g/L) 0.7±0.6 0.1-1.9 2.1±0.1
FII (%) 91.4±35.7 50-189 100±4
FV (%) 60.6±56.0 11-211 111±9
FVII (%) 130.8±98.1 56-371 132±34
FVIII (%) 137.1±129.9 51-529 135±8
FIX (%) 63.7±20.7 28-95 100±4
FX (%) 112.7±54.8 63-232 128±24
FXI (%) 107.9±34.5 70-177 131±6
FXII (%) 73.1±43.3 12-148 113±14
FXIII act (%) 45.8±18.8 25-75 100
FXIII ag (%) 79.5±18.4 66-105 60-150
vWF (%) 105.0±66.1 46-210 50–150
T-AT (µg/mL) 63.3±23.8 25-93 4±0
Protein C (%) 41.1±38.1 2-109 89±7
AT-III act (%) 111.1±26.8 73-163 94
PLG (%) 45.2±13.0 30-78 76±9 
α2-AP (%) 51.4±21.3 28-96 106±9 
PAI (AU/mL) 18.0±10.2 2-33 12±4 
FDP (µg/mL) 70.0±107.3 3-384 3±0 
D-Di (µg/mL) 26.6±38.8 1-128 0.5±0
Number of volunteers = (5-7), F-factor, vW = von Willebrand, T-thrombin, AT = Antithrombin, act = activity, ag = antigen
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on citrated plasma (160 mM sodium citrate with 2% 
antilonomic serum). This serum was added to prevent 
further in vitro activity of the venom. Plasma aliquots 
for fibrinogen determination were mixed with 50 µL of 
10% EACA (Ipsilon, Química e Farmacêutica, NIKKHO 
Brazil LTDA, RJ, Brazil) before freezing. The plasma 
was immediately stored at -20 °C. Frozen aliquots were 
transported on dry ice to the IBu (SP) and maintained at 
-70 °C until testing. All plasma samples were examined 
within three months of collection. 
Assays
At the HSVP, the whole blood clotting time (WBCT)20, 
activated partial thromboplastin time (APTT) (Roche 
Diagnostics, Switzerland), and prothrombin time (PT) 
(Baxter Healthcare Corporation, Morgantown, WV, USA) 
were assayed. Additionally, hematological and biochemical 
assays were performed, and the platelet count was 
determined using conventional methods.
Human plasma samples deficient in the following 
factors were used for the clotting factor assays: II, VIII, 
X, and XI (Behringwerke, Brazil); VII and IX (Baxter 
Healthcare Corporation, USA); XII (American Diagnostics, 
Germany); and V (prepared in the laboratory)21. The factor 
XIII level, antithrombin III activity, protein C (PC; Staclot 
protein C assay) level, plasminogen (PLG; Stachrom 
PLG) level, and alpha2-antiplasmin (α2-AP; Stachrom 
antiplasmin) level were tested using Diagnostica Stago 
kits (Asnieres, France). Plasminogen activator inhibitor- 1 
(PAI-1; Spectrolyse - enzymatic) was measured with an 
American Diagnostics kit. Immunological tests were used 
to measure the degradation products of fibrin/fibrinogen 
(FnDP/FgDP), and thrombin-antithrombin antigen (T-AT) 
was measured using an EIA kit system (Behringwerke, 
Brazil). Cross-linked fibrin fragments (D-dimer–[D-Di]) 
were measured using a latex agglutination immunoassay 
(Diagnostica Stago), and fibrinogen levels were assayed 
using the colorimetric method22. Total plasma protein was 
assayed via the method of Markwell et al.23 and haptoglobin 
was measured by electrophoresis on cellulose acetate24.
RESULTS 
The majority of the 14 patients (Ps) were classified 
as Grade I (n=8), two were classified as grade II, two as 
Grade III, and two as Grade 0 (Table 1). After admission, 
the patients did not receive any specific treatment with the 
exceptions of P12 who had received a blood transfusion 
before she arrived at HSVP and P14 who received a 
transfusion of erythrocytes and the antifibrinolytic drug 
ε-amino-caproic acid (EACA). Two asymptomatic patients 
were excluded. Thus, the recoveries of the hemostatic 
parameters were assayed in 12 patients. 
The time that elapsed from the accident to admission 
to the hospital varied between 4 and 120 h. There was no 
relationship between this period and the seriousness of the 
envenomation, although the more severe cases were the 
patients who arrived at the hospital less than 24 h or more 
than 48 h after the accident (Table 1). Bleeding ceased 
without treatment within 48 h in all GII cases and in one 
GIII patient. 
An overview of the envenomation kinetics (Figures 1, 2) 
of these patients revealed accentuated fibrinogen reductions 
during the first hours after the accident that increased the 
hemostatic levels, but these levels did not reach the normal 
values. The coagulation and fibrinolytic factor assays of the 
12 patients upon admission are presented in Table 2. Marked 
decreases in the levels of factors V and XIII and Protein C 
(PC) in the patients were observed during the initial hours 
after envenomation (Table 2). The FXIII activity levels 
remained at 50% even after 192 h. In contrast, the FXIII 
antigen levels remained within the normal range. The 
majority of the patients presented with FV levels between 
70 and 100% at 72 h after envenomation. Accentuated 
decreases in PC were observed in all envenomation grades, 
and these values remained below normal during the analysis 
period (Figure 1). The recuperations were slower in the GII 
and GIII patients (> 120 h) than in the GI (> 72 h) patients 
(data not shown). Factor II was decreased upon admission in 
one mild case (58%) and one severe case (50%), and these 
levels remained decreased for 3 to 5 days (60 and 70%). 
Similarly, factor VIII levels were also decreased in three 
patients (51%), whereas two patients exhibited increased 
levels (529% and 151%). The majority of the patients 
exhibited slightly reduced FIX levels (44-81%) with the 
exception of one patient who had a normal level (102%) 
120 h after the accident. Regarding FXII, there were no 
changes with the exceptions two patients who presented 
with low levels (12 and 15%). Von Willebrand factor and 
ATIII activity levels were normal in most of the patients, 
but one patient presented with an increased vWF level at 
29 h (210%). Furthermore, the ATIII antigen levels were 
increased in 6/11 patients (between 196 and 200%). The 
T-AT complex levels were increased upon admission in all 
patients (25-93 µg/mL); however, these levels normalized 
during the evolutions of the conditions (Figure 2). 
The plasminogen and α2-antiplasmin levels were reduced 
upon admission. Both parameters increased but did not reach 
normal levels during the analysis period. Slight increases in 
the PAI-1 levels were observed at 6 and 24 h, PAI-I levels 
returned to normal after these time points (Figure 2). The 
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Figure 1 - Time-course of fibrinogen, factor V, factor XIII-ag, factor XIII-act, factor VIII and protein C consumption of 10 patients 
after contact with the Lonomia obliqua caterpillar. ag- antigen, act- activity, Bars represent the mean ± SEM. Numbers over bars 
= number of patients.
Figure 2 - Time-course of fibrin/fibrinogen degradation products (FnDP/FgDP), cross-linked fibrin fragment (D-Dimer), α2-antiplasmin, 
thrombin-antithrombin antigen (T-AT), plasminogen and plasminogen activator inhibitor (PAI) consumption of 10 patients after contact 
with the Lonomia obliqua caterpillar. Bars represent the mean ± SEM. Numbers over bars – number of patients
Sano-Martins et al.
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FnDP/FgDP and D-Di levels were increased in nearly 
all patients primarily at 6-7 h after the accidents. Higher 
levels (FnDP/FgDP: -384 µg/mL and D-Di-128: µg/mL) 
were observed in one patient. All patients returned to normal 
levels after 120 h (Figure 2).
The hematological patient data that were collected upon 
admission (n=8) revealed only one anemic patient with 
internal bleeding (2.5 x 1012 red cells, 22% hematocrit and 
7.6 g/L hemoglobin). Slight leukocytosis with differential 
counts that remained within normal limits was observed. 
Three of the patients presented with moderate leukocytosis 
(12-14.0x109/L) without any significant alterations, and 
only a single patient presented with neutrophilia without 
a leftward deviation. Thrombocytopenia was observed in 
only one patient at 40 h after admission (51 x 109/L), and 
the platelet level remained below normal (65 x 109/L) even 
after 72 h. One patient who was admitted with normal 
platelet levels exhibited a slight decrease at 120 h after the 
accident (131 x 109/L). Four patients exhibited reduced 
total protein levels (4.9 – 5.8 g/dL) that did not return to 
normal (7.0 ± 0.5) until they were discharged, and the other 
patients exhibited levels between 6.0 and 7.4 g/dL during the 
analysis period. Low haptoglobin levels (1.3-1.7 g/L) were 
observed in 3 of 5 studied patients and probably resulted 
from subclinical hemolysis.
DISCUSSION
This is the first study of patients (n=12) who had been 
envenomed by contact with the L. obliqua caterpillar to 
conduct monitoring and long-term follow-up of the clinical 
and (laboratory) coagulation parameters until discharge.
The patients bleeding disorders following contact with 
the caterpillars were spontaneous and occurred in any part 
of the body but generally occurred in areas that were injured 
or had previous wounds.
The patients with low fibrinogen levels also presented 
with low FV, PC, FXIII, PLG and α2-AP levels. In contrast, 
these patients exhibited higher T-AT, FnDP/FgPD, and 
D-Di levels, which suggests the occurrence of disseminated 
intravascular coagulation (DIC) and fibrinolysis activation. 
Our follow-up laboratory data indicated that there was no 
relationship of the time elapsed from the accident until 
hospital admission with the severity of the condition. 
However, the GI patients who were admitted between 
7 and 29 h after the accident exhibited higher levels of 
FnDP/FgDP and D-Di than the patients who were admitted 
96 h after the accident and presented with near normal 
levels. Additionally, the patients who were in critical 
condition (GII and GIII) an arrived at the hospital 48 h 
after the accident exhibited lower levels of FnDP/FgDP 
and D-Di, which suggests that these alterations are 
more strongly related to the time of the accident than 
to the seriousness of the envenomation. Similar results 
have been observed in patients who were poisoned by 
L. achelous caterpillars and presented with low FnDp/
FgDP levels during the first days after envenomation16. 
These consumption coagulopathies seem to be induced 
mainly by the FII and FX procoagulant activators that are 
present in both L. obliqua bristle extracts12,13 and Lonomia 
achelous25,26 as previously proposed elsewhere8,14. 
Despite the formation of intravascular thrombin, which is 
detected as an elevation in the T-AT complex, moderate 
thrombocytopenia (138 x 109/L) was observed in only one 
patient. In Venezuela, patients poisoned by L. achelous 
were treated with purified human fibrinogen with 
aprotinin, and in some cases, EACA was administered 
after aprotinin. In our study, one patient (Grade III) was 
treated with an antifibrinolytic drug (EACA) in Ringer 
solution for three days (total of 15 g), received packed red 
blood cells over four days (1.5 L) and was discharged ten 
days after admission in a normal condition. Since 1995, 
there has been a reduction in the mortality rate due to the 
introduction of an antilonomic serum for the treatment of 
L. obliqua envenomation19,27. Our present study revealed 
a severe consumption coagulopathy characterized by 
hypofibrinogenemia and activation of the fibrinolytic 
system that was prolonged for more than eight days during 
recovery. The abnormalities related to blood coagulation 
and fibrinolytic factors were similar in all the patients in 
the study, which indicates that the severity of the accident 
could not be predicted by changes in the hemostatic 
parameters. Consequently, alterations of coagulation 
without thrombocytopenia do not define the seriousness of 
the accident; however, these parameters are relevant when 
evaluating the patient recovery, and treatment efficacy.
The comparative study between the patient who 
received blood and EACA treatment and the patients who 
did not receive any treatment after admission suggested 
that blood transfusion, even at 120 h, was responsible for 
the significantly lower levels of FV, FXIII, PC and PLG 
and the higher levels of T-AT, which suggests that whole 
blood infusion can be responsible for blood coagulation 
activation as has been found in cases hemorrhagic 
diathesis induced by contact with L. achelous16. However, 
240 h after the accidents, there were no differences in 
the fibrinogen levels, which were at hemostatic levels. 
Moreover, the FXIII levels remained below normal values 
in all patients. 
Material obtained from the venomous fluid of the 
secretory system of L. obliqua has been shown to contain 
an enzyme with fibrinolytic action28. Consequently, in the 
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patients in this study, fibrinolysis could have occurred due 
to the direct action of this enzyme (lonofibrase), which 
may have been responsible for both the primary fibrinolytic 
activity and the secondary fibrinolysis activation that were 
induced by procoagulant activities29. The decrease in PLG 
was not related to the interval between the accident and 
the analysis. In contrast, the PAI-1 levels at 7 and 29 h 
after the accidents were greater than the levels at 48 and 96 
h. Interestingly, all patients, including the asymptomatic 
ones, exhibited FXIII levels that were below normal 
values during the analyzed period. Studies of L. achelous 
hemolymph and its fractions (i.e., lonomin V) have shown 
that this enzyme has a dose-dependent relationship with 
FXIII inactivation, and this effect may play a major role 
in the bleeding syndrome induced in humans30. This 
mechanism could be one of the factors that are involved 
in the hemorrhagic syndrome that occurs following 
L. obliqua exposure, which is also associated with a 
decrease in FXIII. In vitro studies and experimental 
envenomations of rats and rabbits with L. achelous 
caterpillar bristle extract as well as studies in patients 
indicate that FXIII reduction is related to the cleavage 
of subunit A of the factor XIII molecule associated 
with the inhibitor of crosslinking30. Consequently, the 
formation of D-Di is not substantially increased. These 
results suggest that, in vivo, the hemorrhagic syndrome 
can also be provoked by the proteolysis of FXIII. In 
contrast, Zannin et al.9, who obtained data only upon 
patient arrival at the hospital, reported high levels of 
D-Di in the majority of the patients, although some of 
these patients presented with normal levels of fibrinogen. 
Thus, it is important to consider that although some groups 
have reported that no fibrinolytic activity is induced by 
L. obliqua exposure and that any fibrinolytic activities 
are secondary26, another group presented clear evidence 
of fibrinogenolytic activity28,29. Thus, the mechanism of 
this envenomation is not yet entirely understood. Some 
components, such as fibrinogenolytic agents, kininogen, 
serpins, lectins, and PLA2, which have been described in 
a catalog of L. obliqua cDNAs and proteins29, may also 
contribute to the symptoms manifested by patients who 
experience this type of accident. Moreover, kininogens 
have been shown to possess antithrombotic properties in 
vivo at low concentrations of thrombin31. Lonomia obliqua 
bristle extract actives human platelets to induce adhesion 
and aggregation through a calcium-dependent mechanism 
that is triggered by the phospholipase A2 that is present 
in this extract32. Most severely affected patients present 
thrombocytopenia, which is related to morbidity and 
bleeding events. Rats that are experimentally envenomed 
with Lonomia obliqua extract have been shown to 
present with slight thrombocytopenia, but significant 
hypoaggregation induced by intravascular nitric oxide and 
fibrin/ fibrinogen degradation products can be elicited by 
hemostatic disturbances33.
Approximately 2% of patients envenomed via contact 
with L. obliqua caterpillars develop acute renal failure, 
and the administration of antilonomic serum reduces the 
mortality due to the severity of renal impairment; however, 
antilonomic serum does not decrease this incidence27. 
An experimental research has shown that treatment with 
Lonomia antivenom within 2 h of envenomation normalizes 
biochemical alterations, whereas treatment after 6 h does not 
elicit the recovery of these parameters despite the efficacy 
of specific antivenom therapy in reversing hemostatic 
disturbances34.These results may explain the observations 
in 286 patients. The patients who received care more than 
48 h after the contact exhibited a greater probability (11%) 
of progressing to acute renal failure than those who arrived 
at the hospital within the first 48 h (2.9%) indicating that 
the time elapsed between the contact and the hospital care 
is an important factor in terms of the occurrence of acute 
renal failure (HSVP, Passo Fundo, 1989/02 to 1995/07, 
unpublished data, Duarte AC). The mechanism responsible 
for renal dysfunction following the accidental exposure 
in humans is not yet well understood, but hemodynamic 
changes secondary to bleeding or direct nephrotoxicity 
are possible explanations. It has been suggested that 
renal dysfunction could be related to a disseminated 
intravascular coagulation with a massive deposition of fibrin 
in the glomerular capillaries. Cortical and tubular necrosis 
resulting from intravascular coagulation is also possible 
because, in previous studies, 4 of 39 acute renal failure 
cases have never recovered renal function11,27. In our study, 
only one patient, who was admitted to the hospital 48 h 
after the accident, presented with an increased creatinine 
(2.7 mg/ dL) level, which normalized after 24 h. Experimental 
L. obliqua envenomation in rats has been shown to elicit 
acute kidney injury with tubular necrosis associated 
with renal inflammation, fibrosis and increased vascular 
permeability. Additionally, the presence of Lonomia 
venom in the renal tissue is associated with morphological 
and functional alterations that are suggestive of a direct 
nephrotoxic action35.
The patients in this study presented with different 
levels of envenomation and received palliative treatment 
without antilonomic serum therapy, and the laboratory 
parameters normalized after 196 h. However, treatment 
with antilonomic serum must be applied because it is 
the most efficient treatment and reverses the hemostatic 
disturbances as well as the bleeding disorders in less than 
24 h after treatment19.
Sano-Martins et al.
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